$ZNTL Cashflow Statement | Understand Stock

$ZNTL

$2.07 -$0.14 (6.33%) Close

$ZNTL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Operating lease right-of-use asset and fixed asset impairment
IPR&D impairment
Recognized tax gain on IPR&D impairment
Gain on deconsolidation of Zentera, net of tax
Operating lease right-of-use and fixed asset impairment
Noncash consideration portion of Zentera in-process research and development
Share-based compensation
Goodwill impairment
(Gain)/loss on disposal of equipment
Amortization of premiums on marketable securities, net
Non-cash impact of revenues from licensing and sales of intellectual property
Non-cash recognized mark-to-market of equity securities
Accretion of discounts on marketable securities, net
Loss on equity method investment
Deferred income taxes
Deconsolidation of Kalyra
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Operating lease right-of-use assets and liabilities, net

Net cash used in operating activities
Investing activities:
Purchases of marketable debt securities
Proceeds from maturities of marketable debt securities
Deconsolidation of Zentera cash
Proceeds from sale of marketable equity securities
Proceeds from sale of property and equipment
Purchases of property and equipment
Net cash provided by (used in) investing activities
Financing activities:
Proceeds from issuance of common stock, net
Proceeds from the issuance of Series C convertible preferred units, net
Deferred financing costs
Proceeds from issuance of common stock under equity incentive plans
Repurchase of common stock
Net-settlement of restricted stock unit vesting
Contributions from noncontrolling interest owners, net
Net cash (used in) provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental disclosure of cash flow information:
Income taxes paid
Supplemental disclosure of non-cash investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities
Accrued capital expenditures
Costs incurred in connection with initial public offering included in accounts payable and accrued expenses

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash and cash equivalents
Restricted cash, current
Restricted cash, non-current

Comments